Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aminoglycosides in Early Sepsis (AGES)
NCT06712641Phase 4Recruiting
- Start
- Apr 2026
- Primary completion
- Jun 2028
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
A Phase 4 trial of gentamicin in sepsis. Started Apr 2026; status: recruiting.
02
Drugs
gentamicin
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT06712641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06712641.